AliveCor Launches AI-Powered Kardia 12L ECG System in India

The handheld device, approved by the Central Drugs Standard Control Organisation (CDSCO), is the first AI-powered 12-lead electrocardiogram (ECG) system with a single-cable design.

AliveCor has launched its Kardia 12L ECG system in India, after its introduction in the United States.

The handheld device, approved by the Central Drugs Standard Control Organisation (CDSCO), is the first AI-powered 12-lead electrocardiogram (ECG) system with a single-cable design.

Device Features

AliveCor highlighted that conventional 12-lead ECG machines, though standard for diagnosis, can be limited in availability due to their size and complexity. The Kardia 12L, using advanced KAI 12L technology and a reduced leadset, delivers performance comparable to established ECG systems while simplifying use.

The device is battery-operated, weighs 135 grams, and fits in a physician’s lab coat pocket. It also allows for quicker readings without requiring patients to fully disrobe. AliveCor noted that the system requires minimal training, offering portability and convenience in clinical practice.

CDSCO Approval and Clinical Use

The Kardia 12L detects 35 cardiac determinations, including 14 arrhythmias and 21 morphologies. These cover serious conditions such as acute myocardial infarction (MI) and common forms of cardiac ischemia. The system is designed to expand access to accurate cardiac data in varied healthcare settings.

Priya Abani, CEO of AliveCor, said, "Kardia 12L enables physicians to rapidly detect diseases anytime, anywhere, making this critical medical device more accessible than ever before. More importantly, the launch of the Kardia 12L ECG system in India marks a big win for physicians and patients in the country, at a time when the healthcare system has never been more constrained, or more in need of the access and efficiency this type of solution provides."

Stay tuned for more such updates on Digital Health News